VINC Stock Price, Vincerx, Inc. Quote, Chart

Market Summary

USD0.73-0.17

Market Closed

-18.89%

VINC Alerts

GOLDMAN SACHS GROUP INC reported owning 3% of VINC [2024-04-09]

VINC Stock Price

View Fullscreen

VINC RSI Chart

VINC Valuation

Market Cap

15.6M

Price/Earnings (Trailing)

-0.39

EV/EBITDA

-0.07

Price/Free Cashflow

-0.39

MarketCap/EBT

-0.39

VINC Price/Sales (Trailing)

VINC Profitability

Return on Equity

-357.84%

Return on Assets

-220.44%

Free Cashflow Yield

-258.79%

VINC Fundamentals

VINC Revenue

VINC Earnings

Earnings (TTM)

-40.2M

Earnings Growth (Yr)

56.04%

Earnings Growth (Qtr)

49.05%

Breaking Down VINC Revenue

Last 7 days

-14.1%

Last 30 days

-87.9%

Last 90 days

-36.5%

Trailing 12 Months

-50.3%

How does VINC drawdown profile look like?

VINC Financial Health

Current Ratio

2.63

VINC Investor Care

Shares Dilution (1Y)

0.79%

Diluted EPS (TTM)

-1.89

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2021	0	0	0	0
2020	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Vincerx, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Aug 11, 2023	seelenberger alexander a.	bought	9,967	0.9493	10,500	see remarks
Aug 10, 2023	izumi raquel e.	bought	3,199	0.93	3,440	see remarks
Aug 10, 2023	hamdy ahmed md	bought	5,167	0.9569	5,400	see remarks
Aug 10, 2023	thomas tom c	bought	4,750	0.95	5,000	see remarks
Aug 09, 2023	izumi raquel e.	bought	11,735	0.9002	13,036	see remarks
Aug 09, 2023	hamdy ahmed md	bought	15,994	0.9464	16,900	see remarks
Dec 14, 2022	izumi raquel e.	bought	25,427	0.8848	28,738	see remarks
Dec 14, 2022	hamdy ahmed md	bought	30,538	0.8656	35,280	chief executive officer
Dec 14, 2022	thomas tom c	bought	5,810	0.83	7,000	see remarks
Aug 25, 2022	lowe christopher p.	bought	19,138	1.6499	11,600	-

Which funds bought or sold VINC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Mar 18, 2024	KINGDON CAPITAL MANAGEMENT, L.L.C.	added	100	519,750	908,600	0.06%
Mar 11, 2024	VANGUARD GROUP INC	unchanged	-	87,281	605,836	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	65.75	1,951,230	4,034,790	-%
Feb 16, 2024	PRICE T ROWE ASSOCIATES INC /MD/	unchanged	-	6,000	48,000	-%
Feb 15, 2024	BARCLAYS PLC	reduced	-99.1	-3,000	-	-%
Feb 14, 2024	Point72 Asset Management, L.P.	unchanged	-	58,621	406,896	-%
Feb 14, 2024	CITADEL ADVISORS LLC	added	16.9	58,991	232,884	-%
Feb 14, 2024	MILLENNIUM MANAGEMENT LLC	reduced	-6.98	2,506	40,672	-%
Feb 14, 2024	SABBY MANAGEMENT, LLC	sold off	-100	-57,927,000	-	-%
Feb 14, 2024	LMR Partners LLP	new	-	11,800	11,800	-%

Are Funds Buying or Selling VINC?

Are funds buying VINC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VINC

No. of Funds

VINC Alerts

GOLDMAN SACHS GROUP INC reported owning 3% of VINC [2024-04-09]

Unveiling Vincerx, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 09, 2024	goldman sachs group inc	3.0%	631,490	SC 13G/A
Feb 14, 2024	long focus capital management, llc	5.1%	1,098,753	SC 13G/A
Feb 13, 2024	affinity asset advisors, llc	12.%	0	SC 13G/A
Feb 13, 2024	bank of america corp /de/	5.1%	1,082,863	SC 13G
Feb 05, 2024	goldman sachs group inc	8.0%	1,709,656	SC 13G/A
Feb 14, 2023	long focus capital management, llc	6.7%	1,414,951	SC 13G
Feb 13, 2023	affinity asset advisors, llc	7.04%	1,492,771	SC 13G/A
Feb 10, 2023	rubric capital management lp	1.83%	386,719	SC 13G/A
Feb 10, 2023	goldman sachs group inc	10.1%	2,147,849	SC 13G/A
Feb 08, 2023	goldman sachs group inc	9.8%	2,076,874	SC 13G

Recent SEC filings of Vincerx, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	8-K	Current Report
Apr 25, 2024	424B5	Prospectus Filed
Apr 25, 2024	8-K	Current Report
Apr 10, 2024	ARS	ARS
Apr 10, 2024	DEF 14A	DEF 14A
Apr 10, 2024	DEFA14A	DEFA14A
Apr 09, 2024	SC 13G/A	Major Ownership Report
Apr 08, 2024	8-K	Current Report
Mar 29, 2024	424B5	Prospectus Filed
Mar 29, 2024	10-K	Annual Report

Peers (Alternatives to Vincerx, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	41.2B	6.8B	-2.42%	-17.04%	-8.75	6.02	-64.45%	-156.37%
HILS	22.4B	152.6K	-0.77%	465779.94%	-2.4K	146.8K	-	-9.98%
ALNY	18.0B	1.8B	-7.18%	-26.90%	-41	9.87	76.23%	61.08%
BMRN	15.4B	2.5B	-8.70%	-12.49%	74.73	6.21	13.74%	186.89%
INCY	11.6B	3.7B	-9.54%	-29.84%	19.41	3.14	8.87%	75.42%
MID-CAP
APLS	6.0B	396.6M	-14.77%	-39.78%	-11.37	15.16	425.83%	18.94%
BBIO	4.4B	-	-19.35%	75.41%	-6.7	60.35	54.84%	-34.79%
AXSM	3.4B	270.6M	-9.32%	0.89%	-14.22	12.57	440.80%	-27.84%
ACAD	2.8B	726.4M	-8.24%	-18.54%	-44.9	3.79	40.45%	71.62%
ARWR	2.7B	240.7M	-22.93%	-36.73%	-9.23	12.18	-1.03%	-92.09%
SMALL-CAP
CPRX	1.8B	398.2M	-8.48%	-5.52%	24.58	4.41	85.90%	-14.05%
NVAX	569.6M	983.7M	-16.08%	-46.16%	-1.05	0.58	-50.36%	17.16%
CRBP	361.2M	881.7K	-3.23%	346.43%	-8.1	466.16	-77.61%	-5.33%
INO	247.0M	4.9M	-18.88%	12.93%	-1.83	50.76	-54.97%	51.71%
IBIO	6.1M	2.1M	-47.62%	62.96%	-0.22	2.14	-13.45%	66.37%

Vincerx, Inc. News

Latest updates

Vincerx, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In null)

Income Statement (Quarterly)
Description	(%) Q/Q	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q1
Revenue	-100.0%	-	15,359	3,349	-	-	-
Operating Expenses	3.1%	17,931	17,393	9,625	10,372	305	4.00
S&GA Expenses	-14.6%	5,720	6,695	4,791	3,256	305	4.00
EBITDA Margin	-187.8%	-0.01*	0.00*	-	-	-	-
Interest Expenses	-100.0%	-	25.00	-	-	-	-
Income Taxes	-	25.00	-	-	-	-	512*
Earnings Before Taxes	-	-	-	-	-	-	-10.95
EBT Margin	-131.6%	-0.01*	0.00*	-	-	-	-
Net Income	-1105.7%	-24,524	-2,034	-6,276	-16,276	-307	-4.00
Net Income Margin	-357.0%	-3.04*	-0.67*	-	-	-	-
Free Cashflow	-26.0%	-10,304	-8,175	-3,437	-2,135	-121	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																	(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q2
Assets	-30.7%	18.00	26.00	35.00	47.00	59.00	72.00	88.00	104	118	129	91.00	58.00	63.00	66.00	66.00	67.00	-
Current Assets	-35.4%	15.00	23.00	32.00	44.00	56.00	67.00	82.00	98.00	112	123	87.00	54.00	63.00	1.00	1.00	1.00	0.00
Cash Equivalents	-15.2%	13.00	15.00	7.00	4.00	12.00	46.00	81.00	97.00	112	123	86.00	53.00	62.00	0.00	1.00	1.00	0.00
Net PPE	-8.8%	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-
Liabilities	-33.6%	7.00	11.00	11.00	13.00	12.00	13.00	13.00	15.00	17.00	29.00	20.00	32.00	38.00	4.00	3.00	3.00	-
Current Liabilities	-36.6%	6.00	9.00	9.00	11.00	9.00	10.00	10.00	12.00	14.00	25.00	16.00	29.00	38.00	0.00	0.00	0.00	0.00
Shareholder's Equity	-28.7%	11.00	16.00	24.00	34.00	48.00	60.00	74.00	89.00	100	101	72.00	26.00	25.00	5.00	5.00	5.00	0.00
Retained Earnings	-1.6%	-159	-156	-146	-135	-118	-107	-90.82	-72.39	-55.97	-49.50	-24.97	-22.94	-16.66	-0.56	-0.12	-0.01	0.00
Additional Paid-In Capital	-1.1%	170	172	171	170	167	167	165	162	156	150	97.00	57.00	42.00	6.00	5.00	5.00	0.00
Shares Outstanding	0.1%	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	21.00	18.00	15.00	14.00	-	-	-	-
Float	-	-	-	23.00	-	-	-	20.00	-	-	-	131	-	-	-	8.00	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q3
Cashflow From Operations	-20.7%	-8,019	-6,645	-12,697	-13,092	-13,817	-14,872	-15,887	-15,028	-11,486	-10,304	-8,175	-3,437	-2,135	-121	-	-	-
Share Based Compensation	-	-	-	-	-	-	2,290	3,362	5,258	-	6,075	6,637	4,715	-	-	-	-	-
Cashflow From Investing	-61.8%	5,750	15,061	14,804	5,885	-20,383	-20,195	-	-	-8.00	-22.00	-228	-5,000	-	-	-	-	-
Cashflow From Financing	-	18.00	-	93.00	3.00	38.00	-	242	-	283	47,499	-	-	63,891	-	-	66,438	-

VINC Income Statement

2023-12-31

Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
General and administrative	$ 13,636	$ 18,885
Research and development	28,973	49,837
Restructuring	0	2,469
Total operating expenses	42,609	71,191
Loss from operations	(42,609)	(71,191)
Other income (expense)
Change in fair value of warrant liabilities	(47)	6,303
Interest income	1,251	664
Other income (expense), net	1,248	1,240
Total other income (expense)	2,452	8,207
Net loss	(40,157)	(62,984)
Other comprehensive income (loss):
Net foreign currency translation gain (loss)	(40)	69
Net unrealized gain (loss) on marketable securities	74	(74)
Comprehensive loss	$ (40,123)	$ (62,989)
Net loss per common share, basic	$ (1.89)	$ (3)
Net loss per common share, diluted	$ (1.89)	$ (3)
Weighted average common shares outstanding, basic	21,295	21,029
Weighted average common shares outstanding, diluted	21,295	21,029

VINC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 12,782	$ 11,663
Restricted cash	72	70
Short-term marketable securities	0	40,796
Prepaid expenses	51	134
Grant receivable	1,044	1,372
Other current assets	784	1,929
Total current assets	14,733	55,964
Right-of-use assets, net	2,201	3,064
Property, plant and equipment, net	125	177
Other assets	1,158	81
Total assets	18,217	59,286
Current liabilities
Accounts payable	2,497	4,065
Accrued expenses	1,755	3,923
Lease liability	1,162	1,024
Common stock warrant liabilities	191	144
Total current liabilities	5,605	9,156
Lease liability, net of current portion	1,340	2,412
Other noncurrent liabilities	50	50
Total liabilities	6,995	11,618
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.0001 par value; 30,000,000 shares authorized, none issued and outstanding as of December 30, 2023 and 2022	0	0
Common stock, $0.0001 par value; 120,000,000 shares authorized; 21,407,510 shares and 21,242,884 shares issued and outstanding as of December 31, 2023 and 2022, respectively	2	2
Additional paid-in capital	170,324	166,647
Accumulated other comprehensive income (loss)	8	(26)
Accumulated deficit	(159,112)	(118,955)
Total stockholders' equity	11,222	47,668
Total liabilities and stockholders' equity	$ 18,217	$ 59,286

About Vincerx, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

CEO	Dr. Ahmed M. Hamdy M.D.
WEBSITE	https://vincerx.com
INDUSTRY	Biotechnology
EMPLOYEES	41

Vincerx, Inc. Frequently Asked Questions

What is the ticker symbol for Vincerx, Inc.? What does VINC stand for in stocks?

VINC is the stock ticker symbol of Vincerx, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vincerx, Inc. (VINC)?

As of Fri Apr 26 2024, market cap of Vincerx, Inc. is 15.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VINC stock?

You can check VINC's fair value in chart for subscribers.

What is the fair value of VINC stock?

You can check VINC's fair value in chart for subscribers. The fair value of Vincerx, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Vincerx, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VINC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Vincerx, Inc. a good stock to buy?

The fair value guage provides a quick view whether VINC is over valued or under valued. Whether Vincerx, Inc. is cheap or expensive depends on the assumptions which impact Vincerx, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VINC.